DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan*-Reference-Cited by-同舟云学术

DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan*

Published:1997-01 Issue:1 Volume:61 Page:59-69
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Goldberg Michael R.,Lo Man-Wai,Christ David D.,Chiou Rita,Furtek Christine I.,Amit Ohad,Carides Alexandra,Biollaz Jerome,Piguet Valerie,Nussberger Juerg,Brunner Hans R.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

2. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

3. Pharmacology of Nonpeptide Angiotensin II Receptor Antagonists

4. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.

5. Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists—A perspective;Bioorganic & Medicinal Chemistry;2010-12

2. An Automated Electrophysiology Serum Shift Assay for KVChannels;ASSAY and Drug Development Technologies;2008-04

3. The importance of plasma protein binding in drug discovery;Expert Opinion on Drug Discovery;2007-01

4. Does protein binding modulate the effect of angiotensin II receptor antagonists?;Journal of the Renin-Angiotensin-Aldosterone System;2001-03

5. Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin system;British Journal of Clinical Pharmacology;1999-10